Michael Liebowitz, MD, VistaGen CNS Clinical and Regulatory Advisory Board Member and Pivotal Phase 3 Principal Investigator: The Mental Health Impact of COVID-19 Sep 28, 2020
An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics Mar 12, 2020
